Dr. Hadassah Eliora Aaronson

Dr. Hadassah Eliora Aaronson (DR. HADASSAH ELIORA AARONSON ) is A Psychiatry & Neurology Physician in Daytona Beach Shores, FL. The NPI Number for Dr. Hadassah Eliora Aaronson is 1225169238.

The current location address for Dr. Hadassah Eliora Aaronson is 2814 S ATLANTIC AVE STE C Daytona Beach Shores, FL 32118 and the contact number is 2407316929 and fax number is 7037830099. The mailing address for Dr. Hadassah Eliora Aaronson is 2814 S ATLANTIC AVE STE C Daytona Beach Shores, FL 32118- 2407316929 (mailing address contact number - 2407316929).

A psychiatrist or neurologist with special knowledge and skills to prevent and relieve the suffering experienced by patients with life-limiting illnesses. This specialist works with an interdisciplinary hospice or palliative care team to maximize quality of life while addressing physical, psychological, social and spiritual needs of both patient and family throughout the course of the disease, through the dying process, and beyond for the family. This specialist has expertise in the assessment of patients with advanced disease; the relief of distressing symptoms; the coordination of interdisciplinary patient and family-centered care in diverse venues; the use of specialized care systems including hospice; the management of the imminently dying patient; and legal and ethical decision making in end-of-life care.

What is the NPI Number for Dr. Hadassah Eliora Aaronson ?

Answer: The NPI Number for Dr. Hadassah Eliora Aaronson is 1225169238

Where is Dr. Hadassah Eliora Aaronson located?

Answer: Dr. Hadassah Eliora Aaronson is located at 2814 S ATLANTIC AVE STE C Daytona Beach Shores, FL 32118.

What is the specialty for Dr. Hadassah Eliora Aaronson ?

Answer: The Specialty of Dr. Hadassah Eliora Aaronson is A Psychiatry & Neurology Physician.

Are there any online reviews for Dr. Hadassah Eliora Aaronson ?

Answer: Not yet!

Are there any other health care providers in Daytona Beach Shores, FL?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Psychiatry & Neurology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	12
Number of Standardized 30-Day Fills	19
Aggregate Cost Paid for All Claims	171.44
Number of Day's Supply for All Claims	554
Number of Medicare Beneficiaries
Number of Claims, Including Refills, for Beneficiaries Age 65+	0
Including Refills, for Beneficiaries Age 65+	0
Beneficiaries Age 65+	0
Number of Day's Supply for All Claims for Beneficaries Age 65+	0
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs	0
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	12
Aggregate Cost Paid for Generic Drugs	171.44
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	12
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	171.44
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	0
Aggregate Cost Paid for Claims Filled by	0
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	0
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	0
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	12
by Low-Income Subsidy	171.44
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	0
Aggregate Cost Paid for Antibiotic Drugs	0
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	61
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	0.687